Published in J Biol Chem on June 21, 2006
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest (2011) 1.49
Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect Immun (2009) 1.29
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Diverse backbone-cyclized peptides via codon reprogramming. Nat Chem Biol (2009) 1.18
Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J (2011) 1.07
Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr Mol Pharmacol (2010) 1.06
"Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides. Adv Drug Deliv Rev (2009) 1.06
θ-Defensins: cyclic peptides with endless potential. J Biol Chem (2012) 1.05
Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface. J Biol Chem (2012) 1.03
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob Agents Chemother (2007) 1.02
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections. Antimicrob Agents Chemother (2011) 0.99
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol (2010) 0.95
Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect Immun (2008) 0.95
Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities. J Leukoc Biol (2010) 0.94
Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis (2012) 0.87
Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Biochemistry (2013) 0.85
Retrocyclins neutralize bacterial toxins by potentiating their unfolding. Biochem J (2015) 0.85
Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system. Mol Biosyst (2012) 0.85
Designing inhibitors of anthrax toxin. Expert Opin Drug Discov (2014) 0.80
Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections. Pathog Glob Health (2016) 0.80
Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1). Bioorg Med Chem Lett (2012) 0.79
Structure and Biological Functions of β-Hairpin Antimicrobial Peptides. Acta Naturae (2015) 0.79
A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity. Antimicrob Agents Chemother (2014) 0.76
RTD-1mimic containing γPNA scaffold exhibits broad-spectrum antibacterial activities. J Am Chem Soc (2012) 0.76
Multiscale models of the antimicrobial peptide protegrin-1 on gram-negative bacteria membranes. Int J Mol Sci (2012) 0.76
Stone age diseases and modern AIDS. Virol J (2008) 0.75
Targeting and inactivation of bacterial toxins by human defensins. Biol Chem (2017) 0.75
WHAT IF: a molecular modeling and drug design program. J Mol Graph (1990) 24.35
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A (1982) 10.36
Identification of the cellular receptor for anthrax toxin. Nature (2001) 8.78
Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun (1985) 8.46
Anthrax toxin. Annu Rev Cell Dev Biol (2003) 5.92
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem (1986) 5.86
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84
Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods (1991) 4.64
Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol (1999) 4.50
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun (1998) 4.44
Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem (1994) 4.40
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Crystal structure of the anthrax lethal factor. Nature (2001) 3.75
Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc Natl Acad Sci U S A (1989) 3.54
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Primate defensins. Nat Rev Microbiol (2004) 3.29
Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun (1995) 2.87
Stoichiometry of anthrax toxin complexes. Biochemistry (2002) 2.86
Characterization of membrane translocation by anthrax protective antigen. Biochemistry (1998) 2.75
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69
Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A (2002) 2.56
Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A (2002) 2.51
The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A (2002) 2.31
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
The permeability of the wall fabric of Escherichia coli and Bacillus subtilis. J Bacteriol (1996) 2.20
Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14
The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat Struct Mol Biol (2003) 1.91
Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell Microbiol (2000) 1.87
Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A (2005) 1.83
pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol Microbiol (1993) 1.81
Zinc binding in proteins and solution: a simple but accurate nonbonded representation. Proteins (1995) 1.72
Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69
Chemistry. Seamless proteins tie up their loose ends. Science (2006) 1.66
Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry (2000) 1.64
Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci U S A (2003) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol (2004) 1.58
Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55
Circular proteins--no end in sight. Trends Biochem Sci (2002) 1.53
Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol (2005) 1.42
Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides (2003) 1.42
Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem (2001) 1.41
Human neutrophils kill Bacillus anthracis. PLoS Pathog (2005) 1.38
Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci U S A (2005) 1.38
Anthrax vaccines. Curr Top Microbiol Immunol (2002) 1.35
Defensins: antimicrobial peptides of vertebrates. C R Biol (2004) 1.29
Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc (2003) 1.18
Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry (2004) 1.18
Immobilization and aggregation of the antimicrobial peptide protegrin-1 in lipid bilayers investigated by solid-state NMR. Biochemistry (2003) 1.14
Circular minidefensins and posttranslational generation of molecular diversity. J Leukoc Biol (2001) 1.12
Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci (2004) 1.09
CyBase: a database of cyclic protein sequence and structure. Nucleic Acids Res (2006) 1.05
Two states of cyclic antimicrobial peptide RTD-1 in lipid bilayers. Biochemistry (2002) 1.04
Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides. J Pept Res (2003) 1.02
Solid-state NMR investigation of the selective perturbation of lipid bilayers by the cyclic antimicrobial peptide RTD-1. Biochemistry (2004) 1.00
Defensins: endogenous antibiotic peptides from human leukocytes. Ciba Found Symp (1992) 0.96
Genomics-based approaches to gene discovery in innate immunity. Immunol Rev (2002) 0.83
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A (2003) 5.95
Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem (2004) 2.77
Accurate hybrid stochastic simulation of a system of coupled chemical or biochemical reactions. J Chem Phys (2005) 2.44
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest (2012) 2.41
Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A (2003) 2.32
Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano (2010) 2.29
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res (2008) 2.27
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 2.23
Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14
Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11
α-Defensins in human innate immunity. Immunol Rev (2012) 2.10
Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity (2013) 2.03
The transcription factor STAT3 is required for T helper 2 cell development. Immunity (2011) 2.03
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A (2009) 1.94
Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.87
Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol (2009) 1.80
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75
Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano (2011) 1.68
Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol (2006) 1.64
Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol (2009) 1.63
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. J Am Chem Soc (2007) 1.63
Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci U S A (2003) 1.61
STAT6-dependent regulation of Th9 development. J Immunol (2011) 1.60
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood (2005) 1.60
Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc Natl Acad Sci U S A (2013) 1.60
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol (2004) 1.58
Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry (2002) 1.54
Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy (2009) 1.53
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem (2002) 1.53
Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol (2004) 1.50
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol (2005) 1.42
Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides (2003) 1.42
The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses (2003) 1.40
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res (2009) 1.37
Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. J Mol Biol (2008) 1.37
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A (2010) 1.29
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem (2007) 1.28
Determination of peptide oligomerization in lipid bilayers using 19F spin diffusion NMR. J Am Chem Soc (2005) 1.26
Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett (2010) 1.26
Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem (2005) 1.25
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol (2007) 1.23
RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses (2004) 1.23
Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol (2009) 1.22
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 1.21
Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol (2009) 1.20
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques. PLoS One (2010) 1.19
Effects of guanidinium-phosphate hydrogen bonding on the membrane-bound structure and activity of an arginine-rich membrane peptide from solid-state NMR spectroscopy. Angew Chem Int Ed Engl (2008) 1.19
Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin. J Biol Chem (2012) 1.18
Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc (2003) 1.18
Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry (2004) 1.18
Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods (2002) 1.18
HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol (2006) 1.17
Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J Biol Chem (2005) 1.17
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions. J Mol Biol (2010) 1.16
Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol Microbiol (2006) 1.16
Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. J Virol (2005) 1.16
Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol (2008) 1.15
Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR. Biochemistry (2009) 1.15